Advisor Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Advisor Group’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$44K	Hold	1,954	–	–	﹤0.01%	3504
2019 Q3	$28K	Buy	1,954 +12	+0.6%	+$176	﹤0.01%	3760
2019 Q2	$26K	Hold	1,942	–	–	﹤0.01%	3815
2019 Q1	$34K	Hold	1,942	–	–	﹤0.01%	3657
2018 Q4	$26K	Hold	1,942	–	–	﹤0.01%	3641
2018 Q3	$42K	Hold	1,942	–	–	﹤0.01%	3420
2018 Q2	$83K	Sell	1,942 -34	-2%	-$1.56K	﹤0.01%	2668
2018 Q1	$129K	Hold	1,976	–	–	﹤0.01%	2341
2017 Q4	$144K	Hold	1,976	–	–	﹤0.01%	2278
2017 Q3	$181K	Sell	1,976 -33	-2%	-$2.53K	﹤0.01%	1929
2017 Q2	$133K	Buy	2,009 +67	+3%	+$8.29K	﹤0.01%	2084
2017 Q1	$421K	Hold	1,942	–	–	0.01%	1165
2016 Q4	$180K	Buy	1,942 +1,931	+17,555%	+$218K	﹤0.01%	1634
2016 Q3	$2K	Hold	11	–	–	﹤0.01%	4209
2016 Q2	$1K	Buy	+11	New	+$1.36K	﹤0.01%	4288

Other funds holding LUMO

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Advisor Group's LUMO Position: Q4 2019 in Review

Advisor Group held its Lumos Pharma, Inc. Common Stock (LUMO) position steady in Q4 2019 at 1,954 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #3504.

Advisor Group first reported a position in LUMO in Q2 2016 and has held it in 15 quarters since. The position peaked at $421K in Q1 2017. 64 funds tracked by Wall St. Rank hold LUMO as of Q4 2019.

Advisor Group held 1,954 shares of Lumos Pharma, Inc. Common Stock worth $44K as of Q4 2019.
Advisor Group left its Lumos Pharma, Inc. Common Stock share count unchanged in Q4 2019.
Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3504 holding.
Advisor Group first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2016 and has held it in 15 quarters since.
Advisor Group's Lumos Pharma, Inc. Common Stock position peaked at $421K in Q1 2017.
64 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.